NEW YORK (GenomeWeb News) – Singapore's PathGen Dx will develop a pathogen detection diagnostic kit based on the Affymetrix GeneChip platform, the companies said today.

PathGen Dx, a spinoff from the Genome Institute of Singapore, plans to develop a test called the PathChip that will detect the presence of more than 70,000 viral and bacterial genomes in human samples and identify co-infecting pathogens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.